Can a Patient with Prestige LP Cervical Disc Replacement Undergo Radiofrequency Ablation for Thyroid Nodules?
Yes, a patient with a Prestige LP cervical disc replacement can safely undergo radiofrequency ablation (RFA) for thyroid nodules, as the presence of cervical hardware is not listed as a contraindication in current guidelines.
Key Reasoning
The 2025 Chinese Guidelines for Ultrasound-Guided Thermal Ablation of Thyroid Nodules 1 provide comprehensive contraindications for RFA, and cervical spine hardware or implants are notably absent from this list. The specific contraindications outlined are:
Absolute Contraindications 1:
- Severe bleeding tendency
- Severe cardiopulmonary insufficiency or other systemic diseases preventing tolerance or cooperation with thermal ablation
- Contralateral vocal cord paralysis on the treatment side
- Pregnancy and lactation (use with caution)
Additional Considerations for Malignant Nodules 1:
- Diffuse sclerosing papillary carcinoma
- Pathologic types other than papillary thyroid carcinoma (PTC)
Technical Feasibility
The RFA procedure is performed under local anesthesia with 1-2% lidocaine 1 using an 18G cooled electrode 2. The needle insertion approach is typically via the isthmus or lateral neck region 1, which should not interfere with posterior cervical spine hardware. The moving-shot technique used in thyroid RFA 2 involves sequential small ablations starting posteriorly and moving anteriorly, maintaining safety margins from critical structures.
Important Caveats
Pre-procedural Assessment Required 1:
Imaging evaluation must include:
- Expert cervical ultrasound to study neurovascular anatomical relationships
- Neck CT if concerns exist about spatial relationships with surrounding structures
- The CT can simultaneously assess the position of the cervical disc hardware relative to the thyroid nodule
Laboratory requirements 1:
- Complete blood count and coagulation function
- Thyroid function tests and calcitonin
- Blood biochemistry
Anticoagulation Management
If the patient is on anticoagulation related to the cervical disc replacement (though uncommon), anticoagulant medications must be discontinued prior to the procedure 1, 2 with appropriate bridging if necessary.
Safety Profile
RFA for thyroid nodules has a complication rate of 1.7% to 3.5% 1, with the most common issues being:
- Transient voice changes (0.5%-7.9%) 1
- Pain (managed with additional anesthesia or analgesics) 1
- Bleeding/hematoma (0.35%-17%) 1
- Permanent vocal cord paralysis is exceedingly rare (0.04%-0.17%) 1
The presence of cervical hardware does not increase these risks, as the procedure is performed anteriorly in the neck with ultrasound guidance, maintaining distance from posterior cervical structures.
Clinical Algorithm
Step 1: Confirm RFA indication based on nodule characteristics (benign nodules ≥2cm causing symptoms, or select malignant nodules meeting specific criteria) 1
Step 2: Obtain neck CT to visualize spatial relationship between thyroid nodule, critical neurovascular structures, and cervical disc hardware 1
Step 3: Complete laboratory assessment including coagulation studies 1
Step 4: If anatomical relationships are favorable and no other contraindications exist, proceed with RFA using standard technique 2
Step 5: Maintain ultrasound visualization throughout to ensure needle trajectory avoids posterior structures 2
The Prestige LP cervical disc is a metal implant positioned posteriorly in the cervical spine, while thyroid RFA is performed anteriorly with needle insertion through the isthmus or lateral approach. These anatomical planes do not intersect, making the procedure technically feasible and safe.